Aurobindo Pharma USA, Inc. Initiates Voluntary Nationwide Recall of Two (2) Lots of Quinapril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, Due to the Detection of N-Nitroso Quinapril Impurity
East Windsor, New Jersey, Aurobindo Pharma USA, Inc. has initiated a voluntary recall of two (2) lots (refer table below) of Quinapril and Hydrochlorothiazide Tablets USP 20mg / 12.5mg, to the consumer level from the US market due to presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 25, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Pfizer Voluntary Nationwide Recall of Lots of Accuretic (Quinapril HCl/Hydrochlorothiazide), Quinapril and Hydrochlorothiazide Tablets, and Quinapril HCl/Hydrochlorothiazide Tablets Due to N-Nitroso-Quinapril Content
Pfizer is voluntarily recalling Accuretic (quinapril HCl/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril and hydrochlorothiazide and quinapril HCl/ hydrochlorothiazide) to the patient(consumer/user) level due to the presence (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 5, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Class 2 Medicines Recall: Pfizer Limited, Accuretic 10/12.5 mg film-coated tablets
Pfizer Ltd are recalling batch number DD4842 as a precautionary measure due to the identification of a nitrosamine above the acceptable limit. Following testing, N-nitroso-quinapril, has been observed (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 28, 2022 Category: Drugs & Pharmacology Source Type: news
Pfizer Recalls Some Blood Pressure Drugs, Citing Cancer Risk
The move follows recalls of other medications found to have higher levels of potential carcinogens. (Source: NYT Health)
Source: NYT Health - March 23, 2022 Category: Consumer Health News Authors: Christina Jewett Tags: Drugs (Pharmaceuticals) Recalls and Bans of Products Cancer Food and Drug Administration Pfizer Inc your-feed-healthcare Accuretic nitrosamine valsartan Valisure ranitidine N-nitrosodimethylamine ndma metformin benzene Source Type: news
Pfizer Voluntary Nationwide Recall of Lots of ACCURETICTM (Quinapril HCl/Hydrochlorothiazide), Quinapril and Hydrochlorothiazide Tablets, and Quinapril HCl/Hydrochlorothiazide Tablets Due to N-NitrosoQuinapril Content
Pfizer is voluntarily recalling Accuretic (quinapril HCl/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril and hydrochlorothiazide and quinapril HCl/ hydrochlorothiazide) to the patient(consumer/user) level due to the presence (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 22, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Pfizer Recalls BP Drugs Because of Potential Carcinogen Pfizer Recalls BP Drugs Because of Potential Carcinogen
The voluntary nationwide recall of the antihypertensive Accuretic and two generics was prompted by unacceptable levels of N-nitroso-quinapril, a likely carcinogen, in 11 lots.News Alerts (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 22, 2022 Category: Cardiology Tags: Cardiology News Alert Source Type: news
Pfizer recalls three blood pressure pills after finding elevated levels of cancer causing impurity
Pfizer has recalled the blood pressure drug Accuretic, among others, after discovering nitrosamine impurities. High levels of nitrosamine have been linked to multiple types of cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - March 22, 2022 Category: Consumer Health News Source Type: news
Accuretic (Quinapril HCl/Hydrochlorothiazide) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 5, 2017 Category: Drugs & Pharmacology Source Type: news
